Targeting Aurora Kinase B Attenuates Chemoresistance in Glioblastoma via a Synergistic Manner with Temozolomide
ConclusionElevated AURKB expression was strongly correlated to TMZ resistant acquisition and poor prognosis, furthermore, targeting AURKB would be a potential therapeutic target for GBM patients.
Source: Pathology Research and Practice - Category: Pathology Source Type: research
More News: Brain Tumor | Cancer | Cancer & Oncology | Databases & Libraries | Genetics | Glioma | Pathology | Study | Temodar